A detailed history of Marquette Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Marquette Asset Management, LLC holds 17 shares of NVS stock, worth $1,879. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 17 -0.0%
Holding current value
$1,879
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

SELL
$80.03 - $92.81 $24,009 - $27,843
-300 Reduced 94.64%
17 $1,000
Q3 2022

Oct 06, 2022

SELL
$74.61 - $87.26 $3,581 - $4,188
-48 Reduced 13.15%
317 $24,000
Q1 2022

Apr 26, 2022

BUY
$80.11 - $90.62 $5,207 - $5,890
65 Added 21.67%
365 $32,000
Q3 2020

Oct 27, 2020

SELL
$82.14 - $91.0 $19,795 - $21,931
-241 Reduced 44.55%
300 $26,000
Q2 2020

Jul 21, 2020

BUY
$80.93 - $91.1 $19,504 - $21,955
241 Added 80.33%
541 $47,000
Q1 2020

Apr 08, 2020

BUY
$70.67 - $99.01 $21,201 - $29,703
300 New
300 $25,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Marquette Asset Management, LLC Portfolio

Follow Marquette Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marquette Asset Management, LLC with notifications on news.